Topical compositions containing vitamin C
By optimizing the ratio of ascorbic acid, caffeine and inorganic salts in the local composition, a stable single-phase aqueous composition is formed, and the problems of ascorbic acid stability and synergistic antioxidant are solved, and the anti-aging and skin brightening effects are achieved.
Patent Information
- Application Number
- CN202380036922.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-04-28
- Filing Date
- 2023-04-26
- Publication Date
- 2024-12-06
AI Technical Summary
Ascorbic acid has poor stability in aqueous carriers and existing topically used compositions are difficult to provide synergistic antioxidant and anti-aging effects, while there are stability challenges.
A single-phase aqueous composition containing ascorbic acid, caffeine and inorganic salts was developed to form a slurry form of high content of ascorbic acid and caffeine by optimizing the component ratio and preparation method, combining sodium bisulfite and 1,3-propylene glycol, etc. Ingredients to form a stable monohydrate composition.
The high stability and synergistic antioxidant activity of ascorbic acid are achieved, providing excellent anti-aging and skin brightening effects, significantly improving the cosmetic properties of the composition.
Smart Images

Figure BDA0005105228360000051 
Figure BDA0005105228360000121 
Figure BDA0005105228360000131
Abstract
Description
Technical Field
[0001] The present invention provides a topical composition comprising a combination of ascorbic acid, caffeine, an inorganic salt and water, which composition is a single-phase aqueous composition. Background Art
[0002] Ascorbic acid (vitamin C) is widely used in skin care for its antioxidant and skin lightening properties. Typically, anhydrous formulations are employed because the stability of ascorbic acid in aqueous carriers is known to be challenging, as water increases the oxidative dynamics of ascorbic acid.
[0003] Caffeine is also known to provide certain skin care benefits when used topically.
[0004] Applicants have now discovered improved topical compositions which are single phase aqueous compositions, preferably in the form of slurries containing high levels of ascorbic acid and caffeine. These compositions advantageously provide synergistic antioxidant activity and excellent anti-aging and skin lightening benefits. They also contain inorganic salts such as sodium bisulfite and are highly stable. Summary of the invention
[0005] The present invention provides a topical composition comprising from about 5 wt % to about 22 wt % of ascorbic acid based on the total weight of the composition, from about 1 wt % to about 5 wt % of caffeine based on the total weight of the composition, at least 0.2 wt % of an inorganic salt selected from the group consisting of sodium sulfite, potassium sulfite, sodium bisulfite and sodium metabisulfite based on the total weight of the composition, and at least 28 wt % of water based on the total weight of the composition, wherein the composition is a single aqueous phase.
[0006] The present invention also provides a topical composition comprising about 10 weight % of ascorbic acid based on the total weight of the composition, about 2 weight % of caffeine based on the total weight of the composition, about 0.5 weight % of sodium bisulfite based on the total weight of the composition, at least 38 weight % of water based on the total weight of the composition, about 40 weight % of 1,3-propylene glycol based on the total weight of the composition, and about 0.2 weight % of ethylenediaminetetraacetic acid based on the total weight of the composition, wherein the composition is a single aqueous phase.
[0007] The present invention also provides a topical composition comprising about 15 weight % of ascorbic acid based on the total weight of the composition, about 2 weight % of caffeine based on the total weight of the composition, about 0.5 weight % of sodium bisulfite based on the total weight of the composition, at least 33 weight % of water based on the total weight of the composition, about 45 weight % of 1,3-propylene glycol based on the total weight of the composition, and about 0.2 weight % of ethylenediaminetetraacetic acid based on the total weight of the composition.
[0008] The present invention also provides a topical composition comprising about 20 weight % of ascorbic acid based on the total weight of the composition, about 2 weight % of caffeine based on the total weight of the composition, at least 0.5 weight % of sodium bisulfite based on the total weight of the composition, at least 28 weight % of water based on the total weight of the composition, about 45 weight % of 1,3-propylene glycol based on the total weight of the composition, and about 0.2 weight % of ethylenediaminetetraacetic acid based on the total weight of the composition.
[0009] The present invention also provides cosmetic methods for treating the skin comprising topically applying these topical compositions to skin in need of skin lightening or whitening treatment. DETAILED DESCRIPTION
[0010] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the invention belongs. All publications, patent applications, patents, and other references mentioned herein are incorporated herein by reference.
[0011] As used herein, "topically applying" means applying or spreading directly onto the outer skin, scalp, or hair, for example, by hand or with an applicator such as a wipe, roller, or spray.
[0012] As used herein, "cosmetically acceptable" means that the ingredients described by the term are suitable for use in contact with tissue (eg, skin or hair) without undue toxicity, incompatibility, instability, irritation, allergic response, and the like.
[0013] As used herein, a "cosmetically acceptable active agent" is a compound (synthetic or natural) that has a cosmetic or therapeutic effect on the skin or hair.
[0014] The compositions of the present invention are suitable for treating signs of skin aging. As used herein, "signs of skin aging" include the presence of lines, including fine lines and wrinkles, loss of elasticity, uneven skin, scarring, reduced skin thickness, and abnormal or reduced synthesis of collagen, glycosaminoglycans, proteoglycans, elastin, or glycoproteins (including fibronectin). In one embodiment, the signs of aging are selected from the presence of lines, fine lines, wrinkles, loss of elasticity, and abnormal or reduced synthesis of collagen, glycosaminoglycans, proteoglycans, elastin, or glycoproteins (including fibronectin).
[0015] The compositions of the present invention are also suitable for treating skin that needs brightening or whitening treatment. As used herein, the term "brightening" or "whitening" the skin generally refers to brightening, lightening, whitening and / or evening the skin tone, skin color and / or skin color, and / or refers to reducing sallowness, and / or refers to brightening and / or fading hyperpigmentation marks and / or lesions, including but not limited to pigmented spots, melanin spots, age spots, sun spots, age freckles, freckles, simple freckles, pigmented solar keratosis, seborrheic keratosis, melasma, acne marks, post-inflammatory pigmentation, moles, acne, combinations of two or more thereof, etc. "Brightening" or "whitening" the skin also refers to increasing the gloss, vitality, clarity and / or radiance of the skin and / or obtaining a more shiny, vibrant, clear or radiant skin tone appearance or making the skin tone less yellow or sallow. In certain preferred embodiments, "lightening" or "whitening" the skin refers to making the skin tone light and even, increasing skin radiance and / or fading age spots. In certain other preferred embodiments, the present invention relates to compositions and methods for use on skin in need of skin lightening or whitening treatment, the skin being selected from sallow and / or dull skin. In certain other preferred embodiments, the present invention relates to compositions and methods for use on skin in need of skin lightening or whitening treatment, the skin being selected from age spots, freckles, marks left after acne, and combinations of two or more thereof.
[0016] As used herein, "treating" means improving, preventing or reversing a condition, disease or disorder, or at least one identifiable symptom thereof. In one embodiment, "treating" refers to improving, preventing or reversing at least one measurable physical parameter associated with the condition, disease or disorder being treated, which is not necessarily identifiable in or by the subject being treated. In another embodiment, "treating" refers to inhibiting or slowing the progression of a condition, disease or disorder, which may be physical (e.g., stabilizing identifiable symptoms), physiological (e.g., stabilizing physical parameters), or both. In another embodiment, "treating" refers to delaying the onset of a condition, disease or disorder.
[0017] In certain embodiments, the compositions of the invention are administered as a preventive measure.As used herein, "prevention" refers to reducing the risk of developing a given condition, disease, or disorder.
[0018] More broadly, the compositions of the present invention may also be used to treat or prevent cosmetic, dermatological or other conditions and disorders, including but not limited to infections associated with the skin, nails and hair, imbalances or disorders of the skin or mucocutaneous tissues; oral, vaginal and anal mucosa; keratinization disorders; inflammation; changes associated with intrinsic and extrinsic aging, and other changes that may or may not be related to the integumentary system. Manifestations include, but are not limited to, oily skin; acne; rosacea; age spots; blemished skin; eruptions; cellulite; skin disorders; dermatitis; infections of the skin, nails and hair; dandruff; dryness or loosening of the skin, nails and hair; xerosis; inflammation or eczema; elastosis; herpes; hyperkeratosis; hyperpigmentation of the skin; ichthyosis; keratosis; freckles; dark spots; mottled skin; pseudofolliculitis; photoaging and photodamage; pruritus; psoriasis; striae; stretch marks; thinning of the skin, nail plates and hair; warts; wrinkles; mouth or gum disease; irritation, inflammation, redness, unhealthy, damaged or abnormal mucous membranes, skin , hair, nails, nostrils, ear canals, anus, or vaginal disorders; breakdown, defective synthesis or repair of dermal components; abnormal or diminished synthesis of collagen, glycosaminoglycans, proteoglycans, and elastin, and reduced levels of such components in the epidermis; uneven skin tone; uneven and rough surface of the skin, nails, and hair; loss or reduction of the resilience, elasticity, and curlability of the skin, nails, and hair; sagging; lack of skin, nail, and hair lubrication and shine; brittle and split nails and hair; yellowing of the skin; reactive, irritated, or telangiectatic skin; and dull, older-looking skin, nails, and hair. In addition, the compositions of the present invention can be used for general care of the skin, nails and hair; improving skin texture and pores, shine and redness; making the skin soft, smooth, refreshed, balanced, visibly clean, even-toned and brighter; increasing skin fullness and volume; and for skin bleaching and lightening and wound healing; reducing or preventing sweating or perspiration in the underarms, crotch, palms or other parts of the body.
[0019] As used herein, the term "subject" means any animal, preferably a mammal, most preferably a human, to which the composition of the present invention will or has been administered. As used herein, the term "mammal" encompasses any mammal. Examples of mammals include, but are not limited to, cows, horses, sheep, pigs, cats, dogs, mice, rats, rabbits, guinea pigs, monkeys, and humans. In a preferred embodiment, the subject is a human.
[0020] As used herein, "wrinkles" include fine lines, micro wrinkles or macro wrinkles. Examples of wrinkles include, but are not limited to, fine lines around the eyes (e.g., "crow's feet"), forehead and cheek wrinkles, frown lines, and smile lines around the mouth.
[0021] As used herein, "loss of elasticity" includes loss of elasticity or structural integrity of skin or tissue, including but not limited to sagging, loose and loose tissue. Loss of elasticity or tissue structural integrity can be caused by a variety of factors, including but not limited to disease, aging, hormonal changes, mechanical trauma, environmental damage, or is the result of applying products such as cosmetics or drugs to the tissue.
[0022] As used herein, "uneven skin" means a skin condition associated with diffuse or mottled pigmentation that can be classified as hyperpigmentation, such as post-inflammatory hyperpigmentation.
[0023] As used herein, "scarring" means a skin condition associated with redness or erythema.
[0024] As used herein, "cosmetic" means any product that preserves, restores, imparts, stimulates or enhances the physical appearance or appears to enhance beauty or promote youthfulness, especially as it relates to the appearance of tissue or skin.
[0025] As used herein, "cosmetically effective amount" means an amount sufficient to treat or prevent one or more signs of skin aging, but sufficiently low to avoid serious side effects. The cosmetically effective amount of a compound or composition will vary with the following factors: the specific condition being treated, the age and physical condition of the end user, the severity of the condition being treated / prevented, the duration of treatment, the nature of other treatments, the specific compound or product / composition employed, the specific cosmetically acceptable carrier employed, etc.
[0026] As used herein, "substantially free" means that the referenced ingredient is not directly or intentionally added to the formulation. Preferably, "substantially free" means containing less than about 1% of an ingredient. More preferably, "substantially free" means containing less than about 0.5% of an ingredient. Even more preferably, "substantially free" means containing less than about 0.1% by weight of an ingredient. The compositions of the present invention may be completely free of ingredients, i.e., contain no ingredients.
[0027] Unless otherwise indicated, percentages or concentrations refer to weight percentages or weight concentrations (i.e., % (weight / weight)). The weight percentage of an ingredient is based on the total weight of the composition containing the ingredient. Unless otherwise stated, all ranges include endpoints, e.g., "4 to 9" includes endpoints 4 and 9.
[0028] ascorbic acid
[0029] The composition contains ascorbic acid, also known as vitamin C. Ascorbic acid has the following structure:
[0030]
[0031] Based on the gross weight of the composition, the composition can contain about 5% to about 22% by weight of ascorbic acid. Based on the gross weight of the composition, the composition can contain about 8% to about 12% by weight of ascorbic acid. Based on the gross weight of the composition, the composition can contain about 13% to about 17% by weight of ascorbic acid. Based on the gross weight of the composition, the composition can contain about 18% to about 22% by weight of ascorbic acid. Based on the gross weight of the composition, the composition can contain about 10% by weight of ascorbic acid. Based on the gross weight of the composition, the composition can contain about 15% by weight of ascorbic acid. Based on the gross weight of the composition, the composition can contain about 20% by weight of ascorbic acid.
[0032] The compositions can contain unexpectedly high levels of vitamin C that remain stable over time. As is known in the art, compositions containing vitamin C are preferably prepared with excess ingredients to account for some degradation over the shelf life of the product.
[0033] caffeine
[0034] The composition also contains caffeine. The amount of caffeine in the composition may range from about 1 wt % to about 5 wt % based on the total weight of the composition.
[0035] Preferably, the composition contains greater than 1% EGCG based on the total weight of the composition. More preferably, the composition contains about 2% caffeine by weight based on the total weight of the composition.
[0036] Inorganic salt
[0037] The composition also contains an inorganic salt selected from sodium sulfite, potassium sulfite, sodium bisulfite and sodium pyrosulfite. Preferably, the inorganic salt is sodium bisulfite or sodium pyrosulfite or a combination of the two. More preferably, the inorganic salt is sodium bisulfite.
[0038] The amount of inorganic salt in the composition is at least about 0.2 weight percent based on the total weight of the composition.
[0039] Preferably, the composition contains about 0.5 wt % of the inorganic salt, based on the total weight of the composition.
[0040] More preferably, the composition contains about 0.5 weight percent sodium bisulfite based on the total weight of the composition.
[0041] Aqueous carrier
[0042] The composition is a single-phase aqueous solution. Based on the gross weight of the composition, it comprises at least about 28 % by weight of water. For example, based on the gross weight of the composition, the composition may comprise at least about 33 % by weight of water. Based on the gross weight of the composition, the composition may comprise at least about 38 % by weight of water.
[0043] The composition may also contain 1,3-propylene glycol. The amount of 1,3-propylene glycol in the composition is preferably at least about 35% by weight of the composition. More preferably, the amount of 1,3-propylene glycol in the composition is at least 40% by weight by weight of the composition. For example, based on the total weight of the composition, the composition may contain at least about 45% by weight of 1,3-propylene glycol.
[0044] The composition may also contain ethylenediaminetetraacetic acid (EDTA). Based on the total weight of the composition, the amount of EDTA in the composition is preferably 0.1 wt% water. For example, based on the total weight of the composition, the composition may contain about 0.2 wt% EDTA.
[0045] Other cosmetically acceptable active agents
[0046] The compositions may contain one or more additional cosmetically acceptable active agents.
[0047] Such cosmetically acceptable active agents include, for example, other anti-aging agents, other antioxidants, anti-acne agents, shine control agents, antimicrobial agents, anti-inflammatory agents, antifungal agents, antiparasitic agents, topical analgesics, sunscreens, photoprotectants, keratolytics, surfactants, moisturizers, nutrients, other vitamins, energizers, antiperspirants, astringents, deodorants, firming agents, anti-hardness agents, and agents for hair and / or skin conditioning.
[0048] The amount of other cosmetic active agents in the composition may range from about 0.001% to about 20% by weight of the composition, for example, from about 0.005% to about 10% by weight of the composition, such as from about 0.01% to about 5% by weight of the composition, based on the total weight of the composition.
[0049] The cosmetically acceptable active agent may be selected from, for example, alpha hydroxy acids and polyhydroxy acids (such as glycolic acid, lactic acid, malic acid, salicylic acid, citric acid, tartaric acid and gluconolactone), benzoyl peroxide, D-panthenol carotenoids, retinoids (such as retinol and retinyl palmitate), ceramides, polyunsaturated fatty acids, essential fatty acids, enzymes (such as laccase), enzyme inhibitors, minerals, hormones (such as estrogens), steroids such as hydrocortisone, 2-dimethylaminoethanol, copper salts such as copper chloride, polypeptides such as hexapeptides and tripeptides, those containing copper, coenzyme Q10, amino acids (such as proline), vitamins, lactobionic acid, acetyl-CoA, niacin, riboflavin, thiamine, ribose, electron transporters (such as NADH and FADH2), natural extracts (such as from Moringa oleifera), Oleifera) seeds, aloe vera, feverfew (e.g., Chrysanthemum Partheniu (feverfew chamomile) flower / leaf / stem juice), oatmeal, dill, blackberry, paulownia tomentosa, aspen lemon), resorcinol (such as 4-hexylresorcinol), curcumin, glycosamines (such as N-acetylglucosamine), glycosaminoglycans (such as hyaluronic acid and chondroitin sulfate), and derivatives and mixtures thereof.
[0050] Examples of other vitamins include, but are not limited to, vitamin A, B vitamins (such as vitamin B3, vitamin B5, and vitamin B12), vitamin K, and different forms of vitamin E (such as alpha, beta, gamma, and delta tocopherol or mixtures thereof), and their derivatives.
[0051] Examples of other antioxidants include, but are not limited to, water-soluble antioxidants such as sulfhydryl compounds and their derivatives (e.g., N-acyl-cysteine), lipoic acid and dihydrolipoic acid, resveratrol, lactoferrin, and ascorbic acid derivatives (e.g., ethyl L-ascorbic acid, ascorbyl palmitate, and ascorbic acid polypeptides) and epigallocatechin gallate (EGCG). Oil-soluble antioxidants suitable for use in the compositions of the present invention include, but are not limited to, butylated hydroxytoluene, retinoids (e.g., retinol and retinyl palmitate), tocopherols (e.g., tocopheryl acetate), tocotrienols, and ubiquinone. Natural extracts containing antioxidants suitable for use in the compositions of the present invention include, but are not limited to, extracts containing flavonoids and isoflavones and their derivatives (e.g., genistein and diadzein), extracts containing resveratrol, and the like. Examples of such natural extracts include grape seeds, pine bark, and propolis.
[0052] Preferably, the composition comprises another cosmetically acceptable active ingredient selected from hyaluronic acid, feverfew, moringa seed extract, EGCG, N-acetylglucosamine, gluconolactone, niacinamide and ethyl L-ascorbic acid.
[0053] Preferred compositions comprise ascorbic acid, caffeine, sodium bisulfite and hyaluronic acid.Such compositions can comprise about 8 to about 12 wt % (e.g., about 10 wt %) ascorbic acid, about 2 wt % caffeine and about 0.05 wt % hyaluronic acid, all based on the total weight of the composition.
[0054] Topical compositions
[0055] The compositions of the present invention may be applied topically to the skin or hair, preferably the skin.They are single phase aqueous compositions.
[0056] The composition can be formulated into a variety of liquid product types, including but not limited to solutions, lotions, creams, gels, sprays, ointments and lotions. The composition is preferably in the form of a slurry, which is a light and easy to spread on the skin and absorbed by the skin.
[0057] The composition may contain one or more emollients known in the art. As used herein, "emollient" refers to a substance used to prevent or relieve dryness, such as by preventing water from being lost through the epidermis from the skin. Examples of emollients include, but are not limited to, those described in the International Cosmetic Ingredient Dictionary and Handbook edited by Pepe, Wenninger and McEwen, pp. 2930-2936 (American Cosmetic and Fragrance Association, Washington, DC, 9th edition, 2002) (hereinafter, "ICI Handbook"). Examples of particularly suitable emollients include vegetable oils, mineral oils, fatty acid esters, etc.
[0058] The composition may also be formulated as a gel (e.g., an aqueous gel, an alcoholic gel, an alcohol / aqueous gel, or an oily gel using a suitable gelling agent). Suitable gelling agents for aqueous and / or alcoholic gels include, but are not limited to, natural gums, acrylic acid and acrylate polymers and copolymers, and cellulose derivatives (e.g., hydroxymethylcellulose and hydroxypropylcellulose). Suitable gelling agents for oils (such as mineral oils) include, but are not limited to, hydrogenated butylene / ethylene / styrene copolymers and hydrogenated ethylene / propylene / styrene copolymers. Such gels typically contain from about 0.1% to 5% by weight of such gelling agents.
[0059] In addition to the above components, the composition may contain a variety of other oil-soluble and / or water-soluble materials that are commonly used in compositions for use on skin and hair at levels established in the art. These materials include humectants, pH adjusters, fragrances, dyes, and preservatives (e.g., parabens).
[0060] The composition may comprise one or more oils. As used herein, the term "oil" means a hydrophobic material such as hydrocarbon oils, silicones, fatty acid derivatives, glycerides, vegetable oils, vegetable oil derivatives, alkyl esters, wax esters, beeswax derivatives, sterols and phospholipids.
[0061] Suitable hydrocarbon oils include petrolatum, mineral oil, microcrystalline wax, squalene, and combinations thereof.
[0062] Silicone oils include dimethicone, dimethiconol, phenyl dimethicone, and cyclic polysiloxanes, and combinations thereof. Silicone oils having a viscosity of from about 0.5 to about 100,000 centistokes at 25°C may also be used in the composition.
[0063] Glycerides include castor oil, sunflower seed oil, coconut oil and derivatives, vegetable oils and derivatives, palm oil, jojoba oil, shea butter, lanolin, and combinations thereof.
[0064] Alkyl ester oils include, but are not limited to, isopropyl esters of fatty acids and esters of long-chain fatty acids. More preferably, the following alkyl esters are available: isopropyl palmitate, isopropyl myristate, myristyl myristate, isohexyl palmitate, decyl oleate, isononyl isononanoate, and combinations thereof.
[0065] Preferably, the composition contains caprylyl glycol. More preferably, the composition contains at least about 0.25 wt % caprylyl glycol based on the total weight of the composition. For example, the composition may contain at least about 0.5 wt % caprylyl glycol based on the total weight of the composition.
[0066] The composition may be substantially free of phenoxyethanol.
[0067] pH
[0068] In one embodiment, the topical composition has a pH of about 3.5 to about 4. The composition may include a pH adjuster such as sodium hydroxide.
[0069] The topical composition may include a buffer such as lactic acid, citric acid, malic acid, tartaric acid, gluconic acid, or gluconolactone to maintain pH. Typically, the composition includes about 2% to about 12% by weight, or about 4% to about 8% by weight of a buffer.
[0070] Preparation method
[0071] The composition of the present invention can be prepared using methods well known in the art. However, preferably, the composition is prepared by mixing the ingredients in a specific order to optimize their solubility in the composition. Specifically, the composition according to the present invention is preferably prepared by first adding caffeine to a water / mineral acid mixture in order to completely dissolve the caffeine, followed by adding other ingredients (as needed) and ascorbic acid. Mixing is preferably carried out at an elevated temperature.
[0072] How to treat your skin
[0073] According to the present invention, skin in need of skin lightening or whitening treatment can be treated by topically applying a composition comprising from about 5 wt % to about 22 wt % of ascorbic acid based on the total weight of the composition, from about 1 wt % to about 5 wt % of caffeine based on the total weight of the composition, at least 0.2 wt % of an inorganic salt selected from sodium sulfite, potassium sulfite, sodium bisulfite and sodium metabisulfite based on the total weight of the composition, and at least 28 wt % of water based on the total weight of the composition, wherein the composition is a single aqueous phase.
[0074] Also according to the present invention, skin in need of skin lightening or whitening treatment can be treated by topically applying a composition comprising about 10 weight % ascorbic acid based on the total weight of the composition, about 2 weight % caffeine based on the total weight of the composition, about 0.5 weight % sodium bisulfite based on the total weight of the composition, at least 38 weight % water based on the total weight of the composition, about 40 weight % 1,3-propylene glycol based on the total weight of the composition, and about 0.2 weight % ethylenediaminetetraacetic acid based on the total weight of the composition, wherein the composition is a single aqueous phase.
[0075] Further according to the present invention, skin in need of skin lightening or whitening treatment can be treated by topically applying a composition comprising about 15 weight % ascorbic acid, based on the total weight of the composition, about 2 weight % caffeine, based on the total weight of the composition, about 0.5 weight % sodium bisulfite, based on the total weight of the composition, at least 33 weight % water, based on the total weight of the composition, about 45 weight % 1,3-propylene glycol, based on the total weight of the composition, and about 0.2 weight % ethylenediaminetetraacetic acid, based on the total weight of the composition.
[0076] Further according to the present invention, skin in need of skin lightening or whitening treatment can be treated by topically applying a composition comprising about 20 weight % ascorbic acid, based on the total weight of the composition, about 2 weight % caffeine, based on the total weight of the composition, about 0.5 weight % sodium bisulfite, based on the total weight of the composition, at least 28 weight % water, based on the total weight of the composition, about 45 weight % 1,3-propylene glycol, based on the total weight of the composition, and about 0.2 weight % ethylenediaminetetraacetic acid, based on the total weight of the composition.
[0077] The composition according to the invention comprising ascorbic acid, caffeine, an inorganic salt and water also advantageously and surprisingly provides excellent solubility and stability of the ascorbic acid.
[0078] The following non-limiting examples will further illustrate the present invention.
[0079] Example 1
[0080] A series of compositions were prepared using the ingredients in Table 1.
[0081] Table 1
[0082] Composition No. 1 2 3 4 5 6 INCI name water 39.45 39.35 39.35 39.25 38.45 44.65 1,3-Propanediol 47 47 47 47 47 40 Disodium EDTA 0.2 0.2 0.2 0.2 0.2 0.2 Sodium bisulfite 0 0 0 0.2 0 0.5 caffeine 0 0 0 0 1 2 Ethyl L-ascorbic acid 0 0.1 0 0 0 0 EGCG 0 0 0.1 0 0 0 Caprylyl Glycol 0.25 0.25 0.25 0.25 0.25 0.5 ascorbic acid 12.5 12.5 12.5 12.5 12.5 12.0 Water; Glycerin; Moringa Seed Extract 0.5 0.5 0.5 0.5 0.5 0 Sodium hydroxide 0.1 0.1 0.1 0.1 0.1 0.1 Hydrolyzed Hyaluronic Acid 0 0 0 0 0 0.05 total 100 100 100 100 100 100
[0083] The composition is prepared as follows: When used, add the ingredients in the following order.
[0084] 1. Add water to the main beaker. Start mixing and heat to 50°C.
[0085] 2. Add hydrolyzed hyaluronic acid and mix until dissolved.
[0086] 3. Add disodium EDTA and mix until dissolved.
[0087] 4. Add sodium bisulfite and mix until dissolved.
[0088] 5. Add caffeine and mix until dissolved.
[0089] 6. Add caprylyl glycol and mix until dissolved.
[0090] 7. Add propylene glycol and mix until smooth.
[0091] 8. Add ascorbic acid and mix until dissolved.
[0092] 9. Begin cooling the batch to 25 °C.
[0093] 10. Add sodium hydroxide (20% NaOH solution) to adjust the final pH between 3.5-4.0.
[0094] Example 2
[0095] According to the method described by Ou B, Hampsch Woodill M, Prior RL, the combined antioxidant effect of the combination of ascorbic acid and various other known antioxidants was tested using the oxygen radical absorption capacity (ORAC) assay. Development and validation of an improved oxygen radical absorption capacity assay using fluorescein as a fluorescent probe. J Agric Food Chem. 2001: 49: 4619 (using slightly different excitation / emission wavelength readings and a narrower range of Trolox standards). The assay measures the ability of the antioxidant "chain breaker" to inhibit the fluorescence decrease of fluorescein disodium (FL) induced by the peroxyl radical generator 2', 2'-azobis (2-amidinopropane) dihydrochloride (AAPH). Distilled water was used as a negative control. Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid, a water-soluble analog of vitamin E with antioxidant properties sold by Hoffman-LaRoche) was used as a positive control.
[0096] The final ORAC value was calculated from the regression equation of the net area under the FL decay curve using the formula where area under the curve (AUC) = 1 + (point 1 + point 2 + point 3 + ... + point 15) / point 1. The Trolox standard was then plotted in micromoles versus AUC. The samples were solved using their AUC to obtain values in micromoles (μmol) Trolox equivalents (TE) / ml. Quantification was performed using a Biosystems Cytofluor 4000 fluorometer and software. The ORAC values of the test materials are expressed in μmol TE / ml (TE = Trolox equivalents).
[0097] All components were stored at room temperature and then diluted with distilled water to make aqueous stock solutions for testing. Further dilutions were performed in distilled water within 24 hours of testing.
[0098] The results are shown in Tables 2 and 3, which report two separate test runs.
[0099] Table 2
[0100]
[0101]
[0102] Table 3
[0103]
[0104] The combination of ascorbic acid and 2% caffeine was only one of four combinations that provided synergistic ORAC values. The expected (additive) ORAC value for the combination of ascorbic acid and 2% caffeine was 761 TE / ml. However, the combination surprisingly provided an ORAC value of 1111 TE / ml. The combination increased the antioxidant activity of vitamin C by 48%.
[0105] Example 3
[0106] The stability of ascorbic acid in a composition according to the invention comprising water, ascorbic acid, caffeine, sodium bisulfite and EDTA (Composition 7) was compared to the stability of ascorbic acid in a comparative composition comprising water and ascorbic acid but without caffeine, sodium bisulfite or EDTA (Composition 8). The ingredients in Composition 7 and Composition 8 are shown in Table 4. When prepared, both compositions contained 12% by weight of ascorbic acid.
[0107] Table 4
[0108]
[0109]
[0110] High pressure liquid chromatography (HPLC) was used to determine the ascorbic acid stability in the composition to detect the ascorbic acid content over time. The sample was dispersed and dissolved in the mobile phase, mixed and filtered, and then injected onto a Hypersil ODSC18, 250 x 4.6 mm column with a detection wavelength of 210 nm. The test time and conditions were as follows:
[0111] Room temperature (1 month, 2 months, and 3 months);
[0112] 40°C (1 month, 2 months and 3 months); and
[0113] 50°C (1 week and 2 weeks).
[0114] The results are shown in Table 5, which shows the weight percent of ascorbic acid remaining in the two compositions over time.
[0115] Table 5
[0116] condition Composition 7 Composition 8 weight% weight% 1 month at room temperature 11.682 11.8607 2 months at room temperature 11.559 11.578 3 months at room temperature 11.831 11.506 1 month at 40°C 11.129 11.0757 2 months at 40°C 10.511 9.608 3 months at 40°C 9.772 8.842 1 week at 50°C 11.259 11.183 2 weeks at 50°C 10.45 10.603
[0117] Composition 7 according to the present invention maintained good ascorbic acid stability at all time points and conditions. In contrast, at 40°C, the amount of ascorbic acid in comparative composition 8 was reduced relative to that in composition 7. Specifically, after 2 and 3 months at 40°C, the amount of ascorbic acid in comparative composition 8 was significantly lower than that in composition 7 at the same time points.
Claims
1. A topical composition comprising from about 5% to about 22% by weight of ascorbic acid based on the total weight of the composition, from about 1% by weight of to about 5 wt % caffeine, at least 0.2 wt % of an inorganic salt selected from sodium sulfite, potassium sulfite, sodium bisulfite and sodium metabisulfite, based on the total weight of the composition, and at least 28 wt % of water, based on the total weight of the composition, wherein the composition is a single aqueous phase.
2. The composition of claim 1, further comprising at least 35 wt% of 1,3-propylene glycol based on the total weight of the composition.
3. The composition of claim 1, further comprising at least 0.1 wt% ethylenediaminetetraacetic acid based on the total weight of the composition.
4. The composition of claim 1, wherein the inorganic salt is sodium bisulfite.
5. The composition of claim 1, further comprising hyaluronic acid.
6. A topical composition comprising about 10 weight % ascorbic acid, based on the total weight of the composition, about 2 weight % caffeine, based on the total weight of the composition, about 0.5 weight % sodium bisulfite, based on the total weight of the composition, at least 38 weight % water, based on the total weight of the composition, about 40 weight % 1,3-propylene glycol, based on the total weight of the composition, and about 0.2 weight % ethylenediaminetetraacetic acid, based on the total weight of the composition, wherein the composition is a single aqueous phase.
7. A topical composition comprising about 15 weight % ascorbic acid, based on the total weight of the composition, about 2 weight % caffeine, based on the total weight of the composition, about 0.5 weight % sodium bisulfite, based on the total weight of the composition, at least 33 weight % water, based on the total weight of the composition, about 45 weight % 1,3-propylene glycol, based on the total weight of the composition, and about 0.2 weight % ethylenediaminetetraacetic acid, based on the total weight of the composition.
8. A topical composition comprising about 20 weight % ascorbic acid, based on the total weight of the composition, about 2 weight % caffeine, based on the total weight of the composition, about 0.5 weight % sodium bisulfite, based on the total weight of the composition, at least 28 weight % water, based on the total weight of the composition, about 45 weight % 1,3-propylene glycol, based on the total weight of the composition, and about 0.2 weight % ethylenediaminetetraacetic acid, based on the total weight of the composition.
9. A cosmetic method for treating the skin, the method comprising topically applying the topical composition according to claim 1 to skin in need of skin lightening or whitening treatment.
